D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
LFCR holding history
Lifecore Biomedical, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
LFCR overviewAll 13F holders of LFCRFull Q2 2026 holdings
- Shares (Q1 2026)
- 0
- Sold out in Q1 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 9
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q1 2026 | 0 | $0 | 0.0% | −37,428−100.0% | Sold out | Holders |
| Q4 2025 | 37,428 | $306.2K | <0.1% | +37,428 | New | Holders |
| Q1 2023 | 0 | $0 | 0.0% | −47,971−100.0% | Sold out | Holders |
| Q4 2022 | 47,971 | $310.9K | <0.1% | +1,568+3.4% | Added | Holders |
| Q3 2022 | 46,403 | $413.0K | <0.1% | −4,065−8.1% | Reduced | Holders |
| Q2 2022 | 50,468 | $503.0K | <0.1% | −14,342−22.1% | Reduced | Holders |
| Q1 2022 | 64,810 | $750.0K | <0.1% | +10,219+18.7% | Added | Holders |
| Q4 2021 | 54,591 | $606.0K | <0.1% | +767+1.4% | Added | Holders |
| Q3 2021 | 53,824 | $496.0K | <0.1% | −47,508−46.9% | Reduced | Holders |
| Q2 2021 | 101,332 | $1.14M | <0.1% | +60,011+145.2% | Added | Holders |
| Q1 2021 | 41,321 | $438.0K | <0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.